Login / Signup

An engineered miRNA PS-OMe miR130 inhibits acute lung injury by targeting eCIRP in sepsis.

Timothy BorjasAsha JacobMolly KobritzGaifeng MaChuyi TanVihas PatelGene F CoppaMonowar AzizPing Wang
Published in: Molecular medicine (Cambridge, Mass.) (2023)
PS-OMe miR130 can be developed as a novel therapeutic by inhibiting eCIRP-mediated inflammation and acute lung injury in sepsis.
Keyphrases
  • cell proliferation
  • lipopolysaccharide induced
  • long non coding rna
  • lps induced
  • long noncoding rna
  • septic shock
  • acute kidney injury
  • intensive care unit
  • inflammatory response
  • signaling pathway